Of further note, the affinity of proinsulin and PPI for the insulin receptor is much lower than that of insulin itself (5), thus minimizing undesirable metabolic side effects upon systemic absorption, e.g. hypoglycemia, which we did not observe. The gene discussed is INS; the disease is Hypoglycemia.